Your browser doesn't support javascript.
loading
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.
Khassafi, Fatemeh; Chelladurai, Prakash; Valasarajan, Chanil; Nayakanti, Sreenath Reddy; Martineau, Sandra; Sommer, Natascha; Yokokawa, Tetsuro; Boucherat, Olivier; Kamal, Aryan; Kiely, David G; Swift, Andrew J; Alabed, Samer; Omura, Junichi; Breuils-Bonnet, Sandra; Kuenne, Carsten; Potus, Francois; Günther, Stefan; Savai, Rajkumar; Seeger, Werner; Looso, Mario; Lawrie, Allan; Zaugg, Judith B; Tello, Khodr; Provencher, Steeve; Bonnet, Sébastien; Pullamsetti, Soni Savai.
Afiliación
  • Khassafi F; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Chelladurai P; Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardio-Pulmonary Institute (CPI), Justus-Liebig University, Giessen, Germany.
  • Valasarajan C; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Nayakanti SR; Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardio-Pulmonary Institute (CPI), Justus-Liebig University, Giessen, Germany.
  • Martineau S; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Sommer N; Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardio-Pulmonary Institute (CPI), Justus-Liebig University, Giessen, Germany.
  • Yokokawa T; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Boucherat O; Pulmonary Hypertension and Vascular Biology Research Group of Quebec Heart and Lung Institute, Department of Medicine, Laval University, Quebec, Canada.
  • Kamal A; Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardio-Pulmonary Institute (CPI), Justus-Liebig University, Giessen, Germany.
  • Kiely DG; Institute for Lung Health (ILH), Justus-Liebig University, Giessen, Germany.
  • Swift AJ; Pulmonary Hypertension and Vascular Biology Research Group of Quebec Heart and Lung Institute, Department of Medicine, Laval University, Quebec, Canada.
  • Alabed S; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
  • Omura J; Pulmonary Hypertension and Vascular Biology Research Group of Quebec Heart and Lung Institute, Department of Medicine, Laval University, Quebec, Canada.
  • Breuils-Bonnet S; European Molecular Biology Laboratory, Heidelberg, Germany.
  • Kuenne C; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Potus F; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Günther S; NIHR Biomedical Research Center, Sheffield, UK.
  • Savai R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Seeger W; NIHR Biomedical Research Center, Sheffield, UK.
  • Looso M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Lawrie A; NIHR Biomedical Research Center, Sheffield, UK.
  • Zaugg JB; Pulmonary Hypertension and Vascular Biology Research Group of Quebec Heart and Lung Institute, Department of Medicine, Laval University, Quebec, Canada.
  • Tello K; Pulmonary Hypertension and Vascular Biology Research Group of Quebec Heart and Lung Institute, Department of Medicine, Laval University, Quebec, Canada.
  • Provencher S; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Bonnet S; Pulmonary Hypertension and Vascular Biology Research Group of Quebec Heart and Lung Institute, Department of Medicine, Laval University, Quebec, Canada.
  • Pullamsetti SS; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Nat Cardiovasc Res ; 2(10): 917-936, 2023 10.
Article en En | MEDLINE | ID: mdl-39196250
ABSTRACT
Right ventricular (RV) function is critical to prognosis in all forms of pulmonary hypertension. Here we perform molecular phenotyping of RV remodeling by transcriptome analysis of RV tissue obtained from 40 individuals, and two animal models of RV dysfunction of both sexes. Our unsupervised clustering analysis identified 'early' and 'late' subgroups within compensated and decompensated states, characterized by the expression of distinct signaling pathways, while fatty acid metabolism and estrogen response appeared to underlie sex-specific differences in RV adaptation. The circulating levels of several extracellular matrix proteins deregulated in decompensated RV subgroups were assessed in two independent cohorts of individuals with pulmonary arterial hypertension, revealing that NID1, C1QTNF1 and CRTAC1 predicted the development of a maladaptive RV state, as defined by magnetic resonance imaging parameters, and were associated with worse clinical outcomes. Our study provides a resource for subphenotyping RV states, identifying state-specific biomarkers, and potential therapeutic targets for RV dysfunction.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Función Ventricular Derecha / Disfunción Ventricular Derecha / Remodelación Ventricular / Perfilación de la Expresión Génica Idioma: En Revista: Nat Cardiovasc Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Función Ventricular Derecha / Disfunción Ventricular Derecha / Remodelación Ventricular / Perfilación de la Expresión Génica Idioma: En Revista: Nat Cardiovasc Res Año: 2023 Tipo del documento: Article